ZFX regulates glioma cell proliferation and survival in vitro and in vivo. »
07/25/12

WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. »
01/14/13

Supplement use during an intergroup clinical trial for breast cancer (S0221). »
08/09/12

Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages »
11/27/12

CD24 polymorphisms in breast cancer: impact on prognosis and risk. »
09/07/12

Ianthelline was isolated from the Arctic sponge Stryphnus fortis. The structure of the compound has been previously described. However, only limited bioactivity data are available and little has been reported about the cytotoxic potential of ianthelline since its discovery. In addition, no study has so far aimed at identifying which cellular mechanisms are affected by ianthelline to generate cytotoxicity. »
10/13/12

Genetic variations in microRNA-biogenesis genes and clinical outcomes in non-muscle invasive bladder cancer. »
01/17/13

Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. »
03/21/12

An adenovirus that expresses both interleukin (IL)-12 and granulocyte-macrophage colony-stimulating-factor (GM-CSF) has been proven to be very effective in treating several tumors, but causes serious normal tissue toxicities. »
01/26/13

Artemin (ARTN) has been implicated in promoting oncogenicity, tumor growth and invasiveness in diverse human malignancies. However, the clinical and prognostic significance of upstream ligand binding components, potentially mediating ARTN oncogenicity, largely remain to be determined in mammary carcinoma. »
01/26/13